Sun Pharmaceutical Industries expands the label for Ilumya (tildrakizumab-asmn) to include treatment for adults with active ...

Strides Pharma reports a 17.1% YoY revenue increase in Q2, reaching ₹1,429 crore. Net profit rises 2% amidst stronger growth ...

Sun Pharmaceutical Industries has been ordered to cease production of ophthalmic products at its Assam plant due to quality ...

Merck is set to increase its revenue forecast for the next decade due to successful clinical trials and new acquisitions, ...